Genopole proposes several types of financing for researchers, postdocs and students:
Postdoctoral Allocations
For young researchers who earned their PhDs in France, went abroad for a postdoctoral position and now wish to return to France, Genopole created the Postdoctoral Repatriation Allocation Program. With its budget of €130,000, the allocation funds the salary of these young researchers for two years when they accept a research post within a Genopole laboratory or company.
The Genopole Thematic Actions Incentives (Atiges)
For researchers with public institution training, the Atiges offer the possibility of creating a team within a biocluster research unit. Atige recipients are selected by a scientific committee from candidates responding to a yearly call for candidates made by Genopole. The laureates receive €250,000 over three years with the possibility of funding for technicians, engineers or postdocs needed for constituting a team.
Scholarships
- Master 2
Students having completed a French first-year Master program or equivalent (e.g., Bachelor) with a French academic mention of Assez Bien or equivalent (e.g., ≈ Cum Laude) in research fields of interest to Genopole, particularly genomics, innovative therapies and bioinformatics, are eligible for Master 2 internship scholarships. The recipients are chosen based on the scientific quality of their project and are allocated €3,500 by Genopole to cover six months of internship remuneration.
- High-level training
Genopole created the endowment fund Fondagen to finance high-level international training for PhD students, the Postdoctoral Repatriation Allocation Program and chairs for young researchers. Fondagen grants are attributed by a selection commission.
Cultivate and diffuse innovation in hospitals
GIP Genopole is committed to biomedical research and convinced that innovation must be focused on professional needs and real-world use. Its partnership with the South Île-de-France Medical Center (CHSF), a 1,000-bed pandisciplinary hospital located at the heart of the biocluster, gives Genopole’s researchers and entrepreneurs a privileged opportunity to better understand the concrete needs of patients, healthcare providers and hospital executives.
With the actions it deploys, GIP Genopole aims to:
- strengthen partnerships between researchers and hospital teams;
- ease the launch and completion of clinical studies;
- encourage research by hospital practitioners and projects at the crossroads of academic research and hospital practice, particularly via its annual call for candidates for biomedical research grants;
- favor the emergence of novel, hospital-grown solutions with its Genopole-CHSF call for innovative ideas.